Wednesday, 14 September |
|
|
Wednesday, 14 September |
10:00 – 11:00 |
Meeting of the Board of the Polish Neurological Society
prof. dr hab. n. med. Konrad Rejdak |
|
|
Wednesday, 14 September |
12:30 – 14:00 |
VASCULAR DISEASES
Michał Karliński Dariusz Gąsecki |
12:30 – 12:50 |
How to reduce the door-to-needle time?
lek. Antoni Ferens |
12:50 – 13:10 |
The most unpredictable stroke - brainstem stroke
Małgorzata Wiszniewska |
13:10 – 13:30 |
Hypertension and stroke
Dariusz Gąsecki |
13:30 – 13:50 |
Monitoring of swallowing disorders after stroke
Radosław Kaźmierski |
13:50 – 14:00 |
Discussion
|
14:00 – 15:30 |
NEURORADIOLOGY
Jerzy Walecki Agata Majos |
14:00 – 14:30 |
Stroke-from diagnostics to therapy
Jerzy Walecki Bartosz Mruk |
14:30 – 14:45 |
Multiple sclerosis – from a radiologist’s perspective
Agata Majos |
14:45 – 15:00 |
Parkinson's disease and parkinsonism
Małgorzata Burzyńska-Makuch |
15:00 – 15:30 |
Discussion Panel
Agata Majos Jerzy Walecki |
15:30 – 16:00 |
Break
|
16:00 – 17:00 |
SPONSORED SESSION
|
12:30 – 14:00 |
DEMYELINATING DISEASES
Monika Adamczyk-Sowa Monika Adamczyk-Sowa Mariusz Stasiołek |
12:30 – 12:42 |
CIS – when to diagnose and treat?
Mariusz Stasiołek |
12:42 – 12:54 |
Autoimmune encephalitis
Waldemar Brola |
12:54 – 13:06 |
NMO spectrum disorders – how to diagnose and manage?
Monika Nojszewska |
13:06 – 13:18 |
Diet in MS – facts and myths
Anna Pokryszko-Dragan |
13:18 – 13:30 |
PIRA - a new concept in the perception of DMT effectiveness
Sławomir Wawrzyniak |
13:30 – 13:42 |
Upcoming immunomodulatory therapies in MS
Natalia Niedziela |
13:42 – 14:00 |
Discussion
|
14:00 – 15:30 |
EPILEPSY
Halina Sienkiewicz-Jarosz prof. dr hab. n. med. Konrad Rejdak |
14:00 – 14:20 |
Is refractory epilepsy always refractory?
Joanna Jędrzejczak |
14:20 – 14:40 |
Treatment of status epilepticus
Ewa Nagańska |
14:40 – 15:00 |
Surgical treatment of epilepsy - indications and preoperative evaluation
Danuta Ryglewicz |
15:00 – 15:20 |
Clinical-electroencephalographic correlations in patients with epilepsy in a neurologist's practice
Magdalena Bosak |
15:20 – 15:30 |
Discussion
|
15:30 – 16:00 |
Break
|
16:00 – 17:00 |
SPONSORED SESSION
Living with epilepsy and not going crazy Magdalena Bosak |
16:00 – 16:40 |
Mood disorders in epilepsy: a psychiatrist and neurologist's point of view
Magdalena Bosak Marcin Siwek |
16:40 – 17:00 |
Cenobamate - new drug, new possibilities for epilepsy therapy
Anetta Lasek-Bal |
12:30 – 14:00 |
EXTRAPYRAMIDAL DISORDERS
Sławomir Budrewicz |
12:30 – 12:45 |
New diagnostic criteria for MSA
Joanna Siuda |
12:45 – 13:00 |
Essential tremor – diagnosis the basis of efficient therapy
Urszula Fiszer |
13:00 – 13:15 |
Differential diagnosis of tremor
Magdalena Boczarska-Jedynak |
13:15 – 13:30 |
New techniques for the surgical treatment of tremor
Stanisław Szlufik |
13:30 – 13:45 |
Tics you haven't heard about
Justyna Kaczyńska Piotr Janik |
13:45 – 14:00 |
Mild Parkinsonian signs
Agnieszka Gorzkowska |
14:00 – 15:30 |
PAIN SYNDROMES
Adam Stępień |
14:00 – 14:15 |
Pain management in a historical review of events
Teofan Domżał |
14:15 – 14:30 |
Fibromyalgia - the current state of knowledge
Adam Stępień |
14:30 – 14:45 |
Diagnostic and therapeutic problems of trigeminal neuralgia
Jan Kochanowski |
14:45 – 15:00 |
Complex regional pain syndrome - current diagnostic and therapeutic options
Kazimierz Tomczykiewicz |
15:00 – 15:20 |
Painful ophthalmoplegia - Tolos Hunt syndrome
Izabela Domitrz Piotr Chądzyński |
15:20 – 15:30 |
Discussion
|
15:30 – 16:00 |
Break
|
16:00 – 17:00 |
SPONSORED SESSION
|
16:00 – 16:30 |
Sponsored lecture by
Pain patient needs 'relaxation' - expert debate Małgorzata Malec-Milewska Jarosław Woroń |
12:30 – 14:00 |
NEUROMUSCULAR DISEASES
Magdalena Koszewicz |
12:30 – 12:50 |
Inflammatory myopathy or myopathy after statins
Biruta Kierdaszuk |
12:50 – 13:10 |
Broad clinical spectrum of motor neurone disease
Monika Ostrowska |
13:10 – 13:30 |
Neuropathies with reversible conduction block
Marta Lipowska Anna Potulska-Chromik |
13:30 – 13:50 |
Assessing the function of thin peripheral nerve fibres as an adjunct to standard electrophysiological studies, i.e. what is not seen in neurography
Magdalena Koszewicz |
13:50 – 14:00 |
Discussion
|
14:00 – 15:30 |
DEMENTIA
Joanna Siuda |
14:00 – 14:25 |
The role of neuropsychological examination in the differential diagnosis of mild cognitive disorders
Dorota Zielińska |
14:25 – 14:30 |
Discussion
|
14:30 – 14:55 |
Should dementia in Parkinson's disease and dementia with Lewy bodies be differentiated?
Ewa Papuć |
14:55 – 15:00 |
Discussion
|
15:00 – 15:25 |
FTD spectrum – the various faces of frontotemporal dementia
Ewa Narożańska |
15:25 – 15:30 |
Discussion
|
15:30 – 16:00 |
Break
|
16:00 – 17:00 |
SPONSORED SESSION
|
Wednesday, 14 September |
17:00 – 18:00 |
Welcome
|
|
President of the Polish Neurological Society, Head of the Conference Scientific Committee
prof. dr hab. n. med. Konrad Rejdak |
|
Rector of the Medical University of Lublin
|
|
Discussion Panel - The state of healthcare in the Lublin voivodeship in comparison with the country and Europe
Małgorzata Gałązka-Sobotka |
|
Addresses by invited guests
Krzysztof Żuk –
Mayor
of the City of Lublin Lech Sprawka – Voivode of Lublin |
Thursday, 15 September |
|
|
Thursday, 15 September |
08:00 – 09:00 |
ORAL PRESENTATIONS OF DISTINGUISHED POSTER WORK
|
Thursday, 15 September |
08:00 – 09:00 |
Meeting of the MS and Neuroimmunology Section Board of the PTN
Monika Adamczyk-Sowa |
Thursday, 15 September |
09:00 – 10:00 |
SPONSORED SESSION BY
|
9:00 – 9:10 |
An initiative of the Angels company in Poland
Adam Kobayashi |
9:10 – 9:35 |
Neuroimaging in qualification for mechanical thrombectomy
Adam Kobayashi |
9:35 – 10:00 |
Monitoring the Quality of Stroke Care - Benefits of the ResQ Registry
Michał Karliński |
10:00 – 10:30 |
Lecture sponsored
by Innovations in interventional treatment of acute phase of ischemic stroke Bartosz Karaszewski |
10:30 – 11:00 |
Break
|
09:00 – 10:30 |
SATELLITE SESSION
What 2022 brings new in migraine treatment Wojciech Kozubski |
09:00 – 09:20 |
Why are we talking about migraine?
Izabela Domitrz |
09:20 – 09:40 |
The importance of CGRP in the pathogenesis of migraine
Adam Stępień |
09:40 – 10:00 |
CGRP receptor antagonists in migraine - the role of Rimegepant
Wojciech Kozubski |
10:00 – 10:20 |
Sponsored lecture
What's new in botulinum toxin treatment of chronic migraine? Magdalena Boczarska-Jedynak |
10:30 – 11:00 |
Break
|
09:00 – 10:30 |
SPONSORED SESSION
|
09:00 – 9:45 |
Lecture sponsored by
Dance with Duodopa, or how to make the right therapeutic decisions in patients with Parkinson's disease prof. dr hab. n. med. Jarosław Sławek Katarzyna Markowska Justyna Gawryluk |
09:45 – 10:15 |
Lecture sponsored by
Why brivaracetam? Maria Mazurkiewicz-Bełdzińska Magdalena Bosak |
10:30 – 11:00 |
Break
|
09:00 – 10:30 |
SPONSORED SESSION
|
09:00 – 09:30 |
Lecture sponsored by
"Breakfast with PPMS" - Why do we so rarely recognise and treat PPMS? Monika Adamczyk-Sowa Waldemar Brola |
09:30 – 10:00 |
Morning coffee with the company
Pregnancy and breast feeding in patients with MS Clinical practice and published scientific data prof. dr hab. n. med. Alina Kułakowska Halina Bartosik-Psujek |
10:00 – 10:30 |
Lecture sponsored by
"Today" is different from the perspective of yesterday and tomorrow - time in MS (discussion) prof. dr hab. n. med. Alina Kułakowska Monika Adamczyk-Sowa Dagmara Mirowska-Guzel |
10:30 – 11:00 |
Break
|
Thursday, 15 September |
11:00 – 12:30 |
PRESIDENTIAL PLENARY SESSION
prof. dr hab. n. med. Konrad Rejdak prof. dr hab. n. med. Alina Kułakowska |
|
Presentation of diplomas to Honorary Members of the PTN
prof. dr hab. n. med. Alina Kułakowska prof. dr hab. n. med. Konrad Rejdak |
|
From genetic research to clinical practice using the example of CSF1R -related leukoencephalopathy
Zbigniew Wszołek |
|
Neuroimmunology - the age of monoclonal antibodies
prof. dr hab. n. med. Alina Kułakowska |
|
Possible regeneration/restoration of function in the central nervous system: facts and myths
prof. dr hab. n. med. Konrad Rejdak |
12:30 – 13:00 |
Break
|
13:00 – 13:45 |
GOLDEN PARTNER SPONSORED SESSION
MODERATOR prof. dr hab. n. med. Konrad Rejdak |
13:00 – 13:15 |
Diagnosis of myasthenia gravis
prof. dr hab. n. med. Amelia Evoli |
13:15 – 13:30 |
A new therapeutic option for patients with generalised MG
|
13:30 – 13:45 |
Discussion
|
13:45 – 14:30 |
GOLDEN PARTNER SPONSORED SESSION
Ozanimod - a highly effective therapy for patients with RRMS MODERATOR prof. dr hab. n. med. Konrad Rejdak |
13:45 – 13:55 |
A paradigm shift in the treatment of patients with RRMS
prof. dr hab. n. med. Konrad Rejdak |
13:55 – 14:10 |
What is important in the treatment of RRMS
|
14:10 – 14:25 |
Recent data on the efficacy and safety of ozanimod therapy in patients with RRMS
|
14:25 – 14:30 |
Discussion
|
14:30 – 15:30 |
Lunch break
|
Thursday, 15 September |
15:30 – 17:00 |
REVIEW SESSION: EPILEPSY
prof. dr hab. n. med. Konrad Rejdak Halina Sienkiewicz-Jarosz |
15:30 – 15:55 |
What’s new in epilepsy A.D.2022
prof. dr hab. n. med. Konrad Rejdak |
15:55 – 16:20 |
Autoimmune epilepsies - diagnosis, treatment and course
Halina Sienkiewicz-Jarosz |
16:20 – 16:45 |
When to start and when to stop treatment? -
inclusion and discontinuation of antiepileptic drugs Maria Mazurkiewicz-Bełdzińska |
16:45 – 17:00 |
Discussion
|
17:00 – 17:30 |
Break
|
17:30 – 19:00 |
REVIEW SESSION: VASCULAR DISEASES
Adam Kobayashi |
17:30 – 17:50 |
Networking in stroke - the mission of ESO
prof. Peter Kelly |
17:50 – 18:10 |
New horizons in thrombolytic treatment
Bartosz Karaszewski |
18:10 – 18:30 |
Evolution of the indications for thrombectomy
Anetta Lasek-Bal |
18:30 – 18:50 |
Intracranial atherosclerosis disease - how to treat and how not to treat
Adam Kobayashi |
18:50 – 19:00 |
Discussion
|
15:30 – 17:00 |
REVIEW SESSION: NEUROMUSCULAR DISEASES
Sławomir Michalak |
15:30 – 15:55 |
MMN or SLA: a practical look at the applicable criteria
Wojciech Turaj |
15:55 – 16:20 |
Paraneoplastic syndromes in the diagnosis of nervous system diseases
Sławomir Michalak |
16:20 – 16:45 |
Problems at the three levels of the synapse
|
16:45 – 17:00 |
Discussion
|
17:00 – 17:30 |
Break
|
17:30 – 19:00 |
REVIEW SESSION: HOT TOPICS
prof. dr hab. n. med. Konrad Rejdak |
17:30 – 17:50 |
Molecular biomarkers of multiple sclerosis
Marcin Mycko |
17:50 – 18:10 |
Updated ECTRIMS/EAN Guideline on disease modifying drugs in multiple sclerosis
|
18:10 – 18:30 |
What can we learn from the treatment of optic neuritis subgroups for the treatment of MS, MOG and NMOSD?
|
18:30 – 18:50 |
Future of multiple sclerosis treatment
|
18:50 – 19:00 |
Discussion
|
15:30 – 17:00 |
REVIEW SESSION: DEMENTIA
Joanna Siuda |
15:30 – 15:55 |
Clinical differential diagnosis of dementia syndromes - here and now
Aleksandra Klimkowicz-Mrowiec |
15:55 – 16:00 |
Discussion
|
16:00 – 16:25 |
Biomarkers in the diagnosis of dementia - what lies ahead in the near future
Joanna Siuda |
16:25 – 16:30 |
Discussion
|
16:30 – 16:55 |
Current dementia treatment options
Agnieszka Gorzkowska |
16:55 – 17:00 |
Discussion
|
17:00 – 17:30 |
Break
|
17:30 – 19:00 |
REVIEW SESSION: HEADACHES
Izabela Domitrz |
17:30 – 17:50 |
Pathophysiology of trigeminal autonomic cephalalgias
Wojciech Kozubski |
17:50 – 18:05 |
Differentiation of trigeminal autonomic cephalalgias
Izabela Domitrz |
18:05 – 18:25 |
Pathophysiology of migraines
Adam Stępień |
18:25 – 18:45 |
Controversial methods of treating migraine
Jacek Rożniecki |
18:45 – 19:00 |
Differences in the treatment of migraine in children
Krystyna Mitosek-Szewczyk |
19:00 – 19:30 |
SPONSORED SESSION BY
Anticoagulation - what to look out for as a neurologist |
19:00 – 19:15 |
Practical aspects of anticoagulant treatment
Michał Karliński |
19:15 – 19:30 |
Secondary prevention of stroke in patients with non-valvular atrial fibrillation
with dabigatran
Agnieszka Słowik |
15:30 – 17:00 |
REVIEW SESSION: DEMYELINATING DISEASES
Monika Adamczyk-Sowa Monika Adamczyk-Sowa prof. dr hab. n. med. Alina Kułakowska prof. dr hab. n. med. Konrad Rejdak |
15:30 – 15:45 |
Immunosenescence - aging of the immune system
Monika Adamczyk-Sowa |
15:45 – 16:00 |
RIS – in clinical practice
prof. dr hab. n. med. Alina Kułakowska |
16:00 – 16:15 |
Current MS treatment strategies
Halina Bartosik-Psujek |
16:15 – 16:30 |
Vaccination in patients with multiple sclerosis
Alicja Kalinowska |
16:30 – 16:45 |
Interactions of disease modifying therapies in MS
Dagmara Mirowska-Guzel |
16:45 – 17:00 |
Discussion
|
17:00 – 17:30 |
Break
|
17:30 – 19:00 |
REVIEW SESSION: NEUROPHARMACOLOGY - NEW DRUGS, CLINICAL TRIALS - WHERE IS THE SEARCH FOR NEW DRUGS HEADED?
Iwona Kurkowska-Jastrzębska |
17:30 – 17:50 |
HOT TOPIC - Cannabinoids in neurology - what you need to know?
Dagmara Mirowska-Guzel |
17:50 – 18:10 |
From depletion to neuroregeneration - the future of the therapeutic landscape in neuroimmune disorders
|
18:10 – 18:30 |
Do Bruton's tyrosine kinase inhibitors represent new options for treating multiple sclerosis?
Ewa Krzystanek |
18:30 – 18:50 |
Where are the new antiepileptic drugs taking us - personalized therapy, therapy for specific epilepsy syndromes
Iwona Kurkowska-Jastrzębska |
18:50 – 19:00 |
Discussion
|
Friday, 16 September |
|
|
Friday, 16 September |
08:30 – 10:00 |
SPECIAL SESSION – VIDEO CASES
prof. dr hab. n. med. Jarosław Sławek |
08:30 – 08:40 |
Lower facial dystonia
Justyna Kaczyńska Piotr Janik |
08:40 – 08:45 |
Discussion
|
08:45 – 08:55 |
A 19-year-old patient with progressive intellectual disability and motor impairment
Małgorzata Kowalska Dariusz Koziorowski |
08:55 – 09:00 |
Discussion
|
09:00 – 09:10 |
Young woman with progressive parkinsonism
Magdalena Kwaśniak-Butowska prof. dr hab. n. med. Jarosław Sławek |
09:10 – 09:15 |
Discussion
|
09:15 – 09:25 |
Increased muscle tone – what is it?
Piotr Alster Natalia Madetko Dariusz Koziorowski |
09:25 – 09:30 |
Discussion
|
09:30 – 09:40 |
Different faces of the same disease
Michał Schinwelski Jarosław Dulski Filip Przytuła Jakub Wiśniewski Witold Sołtan Artur Dziadkiewicz prof. dr hab. n. med. Jarosław Sławek |
09:40 – 09:45 |
Discussion
|
09:45 – 09:55 |
Motor disorders in a 33-year-old female patient
Bożena Kłysz Iwona Sarzyńska-Długosz |
09:55 – 10:00 |
Discussion
|
10:00 – 10:30 |
Break
|
08:30 – 10:00 |
REVIEW SESSION: INSTRUMENTAL METHODS OF PREVENTION AND TREATMENT OF NERVOUS SYSTEM DISORDERS
Anetta Lasek-Bal |
08:30 – 08:50 |
Neuromodulation and minimally invasive techniques in the treatment of refractory epilepsy
Magdalena Bosak |
08:50 – 09:10 |
Cyber knife in the treatment of trigeminal neuralgia
Rafał Tarnawski Anetta Lasek-Bal |
09:10 – 09:30 |
Device-based approach to secondary prevention of cardioembolic stroke (PFO, LAA)
Michał Karliński |
09:30 – 09:50 |
Deep brain stimulation in the treatment of Parkinson's disease - current status, development directions
Sławomir Budrewicz |
09:50 – 10:00 |
Discussion
|
10:00 – 10:30 |
Break
|
08:30 – 10:00 |
REVIEW SESSION: SLEEP DISORDERS
Andrzej Bogucki |
08:30 – 08:50 |
Education on sleep disorders for specialists in neurology
Mariusz Siemiński |
08:50 – 09:10 |
Sleep disorders as a risk and prognostic factor in selected neurological diseases
Monika Rudzińska-Bar |
09:10 – 09:30 |
Treatment of sleep disorders in the elderly
Radosław Magierski |
09:30 – 09:50 |
REM sleep behavior disorder as a premotor symptom of α-synucleinopathy
Andrzej Bogucki |
09:50 – 10:00 |
Discussion
|
10:00 – 10:30 |
Break
|
08:00 – 08:30 |
Morning seminar: How to write research papers?
Zbigniew Wszołek |
08:30 – 10:00 |
REVIEW SESSION: NEUROLOGICAL DISEASES AND PREGNANCY
prof. dr hab. n. med. Alina Kułakowska Anna Członkowska |
08:30 – 08:50 |
Stroke in pregnancy and postpartum - a serious challenge for the neurologist
Małgorzata Wiszniewska |
08:50 – 09:10 |
Wilson's disease and pregnancy - clinical implications and recommendations
Tomasz Litwin |
09:10 – 09:30 |
Patient with epilepsy in pregnancy and postpartum - a challenge for the neurologist
Barbara Błaszczyk |
09:30 – 09:50 |
Myasthenia gravis in pregnancy
Marta Lipowska |
09:50 – 10:00 |
Discussion
|
10:00 – 10:30 |
Break
|
Friday, 16 September |
10:30 – 12:00 |
PLENARY SESSION: STRATEGY FOR NEUROLOGY
Halina Sienkiewicz-Jarosz prof. dr hab. n. med. Konrad Rejdak |
10:30 – 10:45 |
General neurology- perspective of EAN
prof. dr med. Claudio Bassetti |
10:45 – 10:55 |
Strategy for neurology- plans and perspectives of PTN
prof. dr hab. n. med. Konrad Rejdak |
10:55 – 11:05 |
Neurology in Poland - what has been achieved - from the perspective of the national consultant
Agnieszka Słowik |
11:05 – 11:15 |
National Board for Neurology - summary of activities, plans and priorities
Halina Sienkiewicz-Jarosz |
11:15 – 12:00 |
Debate: What needs to be changed in Polish neurology and how to do it?
PhD Jakub Gierczyński Maciej Miłkowski prof. dr hab. n. med. Alina Kułakowska prof. dr hab. n. med. Konrad Rejdak Halina Sienkiewicz-Jarosz prof. dr hab. n. med. Jarosław Sławek Agnieszka Słowik |
12:00 – 12:30 |
Break
|
12:30 – 13:30 |
PLATINUM PARTNER SPONSORED SESSION
Improving patient function - the main therapeutic goal in MS and SMA prof. dr hab. n. med. Konrad Rejdak |
12:30 – 12:35 |
Introduction
|
12:35 – 12:50 |
Stopping disease progression and improving function in patients with MS - personalising the treatment
|
12:50 – 13:05 |
Efficacy of TYSABRI in new form of administration - experience with TYSABRI sc, Czech Republic point of view
Ph.D. Dana Horáková, MD, PhD |
13:05 – 13:20 |
The role of nusinersen in the treatment of adult patients with SMA based on real-world clinical practice data
|
13:20 – 13:30 |
Discussion
|
13:30 – 14:00 |
GOLDEN PARTNER SPONSORED SESSION
What is worth paying attention to when choosing Zeposia (ozanimod) for patients with RRMS? - the clinician's perspective Halina Bartosik-Psujek prof. dr hab. n. med. Alina Kułakowska |
14:00 – 15:00 |
Lunch break
|
Friday, 16 September |
14:00 – 15:00 |
Editorial Board Meeting of the journal Neurology Neurosurgery Poland
Zbigniew Wszołek prof. dr hab. n. med. Jarosław Sławek |
Friday, 16 September |
15:00 – 16:30 |
SESJA SPECJALNA - WYZWANIA W ROZWOJU NOWYCH LEKÓW
Agnieszka Słowik prof. dr hab. n. med. Konrad Rejdak Monika Adamczyk-Sowa |
15:05 – 15:25 |
Improving pharmacotherapy in neurology: new therapeutic agents, new indications, or new drug combinations?
Paweł Grieb |
15:25 – 15:45 |
Drug Development in MS: successes and challenges
MD Andrew Galazka |
15:45 – 16:05 |
Development of new drugs in epilepsy - successes and failures
Rafał Marian Kamiński |
16:05 – 16:25 |
Brain Gene Therapy
Mirosław Ząbek |
16:25 – 16:30 |
Discussion
|
16:30 – 17:00 |
Break
|
17:00 – 17:30 |
SPONSORED SESSION BY
|
17:00 – 17:15 |
How to inhibit MS effectively - clinical trials and real world data of okrelizumab
|
17:15 – 17:30 |
Co wiemy o skuteczności i bezpieczeństwie satralizumabu w leczeniu pacjentów z NMOSD AQP4Ab+ ?
Aleksandra Podlecka-Piętowska |
17:30 – 18:30 |
SPONSORED SESSION
New opportunities for multiple sclerosis patients |
17:30 – 17:45 |
Controversies in multiple sclerosis
Introduction prof. dr hab. n. med. Konrad Rejdak Amos D. Korczyn |
17:45 – 18:05 |
How to optimise the treatment of RRMS patients: HETa or escalation?
Debate in CONy style (Controversies in Neurology) prof. dr hab. n. med. Konrad Rejdak prof. dr hab. n. med. Alina Kułakowska |
18:05 – 18:15 |
Opportunities vs. risks of introducing new drugs to treat MS patients
Discussion prof. dr hab. n. med. Konrad Rejdak prof. dr hab. n. med. Alina Kułakowska |
18:15 – 18:30 |
Ofatumumab and siponimod in the treatment of MS patients
Discussion prof. dr hab. n. med. Alina Kułakowska prof. dr hab. n. med. Konrad Rejdak |
15:00 – 16:30 |
REVIEW SESSION: NEUROONCOLOGY
Sławomir Michalak |
15:00 – 15:20 |
Cancer-associated stroke
Przemysław Nowacki |
15:20 – 15:40 |
New trends in glioma brain tumor surgery
Jakub Moskal |
15:40 – 16:00 |
Practical aspects of the dialogue between an oncologist and a neurologist. Challenges during a neurological consultation in a cancer patient
Daria Świniuch |
16:00 – 16:15 |
Update on management options and principles in neurooncology and onconeurology
Sławomir Michalak |
16:15 – 16:30 |
Nervous system symptoms in advanced oncology therapies
Joanna Rybacka-Mossakowska |
16:30 – 17:00 |
Break
|
15:00 – 16:30 |
REVIEW SESSION: EXTRAPYRAMIDAL DISEASES
Sławomir Budrewicz |
15:00 – 15:15 |
Parkinson's disease - a single or multiple disease?
Dariusz Koziorowski |
15:15 – 15:30 |
Congenital ataxias vs. spastic paraplegia
Monika Rudzińska-Bar |
15:30 – 15:45 |
Effect of brain injury on the development of neurodegenerative processes
Sławomir Budrewicz |
15:45 – 16:00 |
Acute conditions in movement disorders
Agata Gajos |
16:00 – 16:15 |
Myoclonias
prof. dr hab. n. med. Jarosław Sławek |
16:15 – 16:30 |
Motor disorders Associated with streptococcal infections
Andrzej Bogucki |
16:30 – 17:00 |
Break
|
17:00 – 18:10 |
SPONSORED SESSION
|
17:00 – 17:45 |
Lecture sponsored by
Alzheimer's disease through the eyes of a psychiatrist Tomasz Sobów |
17:45 – 17:50 |
Discussion
|
17:50 – 18:10 |
Wykład sponsorowany firmy
Why and how to use COMT inhibitors in the treatment of Parkinson's disease? Monika Rudzińska-Bar |
15:00 – 16:30 |
REVIEW SESSION OF YOUNG NEUROLOGISTS
Aleksandra Pietruczuk Małgorzata Kowalska |
15:00 – 15:20 |
Why is it important to be a Member of the Young Neurologists Section in view of the current and planned activities of the Section?
Aleksandra Pietruczuk |
15:20 – 15:50 |
EAN RRFS - Prospects for the scientific and clinical development of young neurologists
prof. Luca Cuffaro, MD (RRFS President) |
15:50 – 16:10 |
Residencies in Poland and Europe - what you need to know before choosing a clinic
Małgorzata Kowalska |
16:10 – 16:30 |
Grant programs in Poland - what mistakes to avoid when applying for a grant?
Lidia Kotuła |
16:30 – 17:00 |
Break
|
17:00 – 17:45 |
SPONSORED SESSION BY
Debate of experts - botulinum toxin in neurology practice prof. dr hab. n. med. Jarosław Sławek Iwona Sarzyńska-Długosz |
17:00 – 17:15 |
How to treat conditions of increased muscle tone?
prof. dr hab. n. med. Jarosław Sławek |
17:15 – 17:30 |
Why post-stroke spasticity can and should be treated?
Iwona Sarzyńska-Długosz |
17:30 – 17:45 |
Discussion
|
17:45 – 18:05 |
Lecture sponsored by
New possibilities in myorelaxant drug therapy Halina Bartosik-Psujek |
Saturday, 17 September |
|
|
Saturday, 17 September |
8:00 – 9:00 |
Meeting of the editorial board of PJNN/PPN
Sławomir Budrewicz |
Saturday, 17 September |
09:00 – 10:30 |
PLENARY SESSION: NEUROLOGY AND THE ARTS
Andrzej Potemkowski Ryszard Podemski Presentation of musical themes |
09:00 – 09:30 |
Great composers in the neurology ward, or the impact of brain diseases on creativity
prof. dr hab. n. med. Jarosław Sławek |
09:30 – 10:00 |
Dementia and art
Andrzej Potemkowski |
10:00 – 10:30 |
The Bieszczady sacrum
Przemysław Nowacki |
10:30 – 10:45 |
Break
|
10:45 – 12:15 |
SPONSORED SESSION BY
SMA – Hot topics 2022 |
10:45 – 11:00 |
Current landscape and new perspectives for the treatment of SMA in Poland
|
11:00 – 11:10 |
Key registration data of rysdyplam
Magdalena Koszewicz |
11:10 – 11:25 |
Evrysdi in the B.102.FM drug programme - practical aspects
Katarzyna Kotulska-Jóźwiak |
11:25 – 11:30 |
Discussion
|
11:30 – 12:10 |
SPONSORED SESSION BY
Agnieszka Słowik |
11:30 – 11:45 |
Importance of the HETA paradigm in achieving therapeutic goals in MS
|
11:45 – 12:00 |
Mavenclad® - benefits of early use in clinical practice
Alicja Kalinowska |
12:00 – 12:10 |
Discussion
|
12:10 – 12:30 |
Break
|
12:30 – 13:30 |
OWN WORKS: INFLAMMATORY DISEASES UN
Monika Adamczyk-Sowa |
12:30 – 12:40 |
Comparative analysis of selected pro-inflammatory chemokines in the cerebrospinal fluid (CSF) depending on vitamin D concentration among patients diagnosed with de novo relapsing-remitting multiple sclerosis (RRMS)
Bożena Adamczyk |
12:40 – 12:50 |
Myelopathy as a rare clinical manifestation of neurosarcoidosis - a case report
Karol Marschollek |
12:50 – 13:00 |
Consciousness disorders in the course of neurosarcoidosis - a case report
Dominika Jakubowicz-Lachowska |
13:00 – 13:10 |
Clippers- syndrome of chronic lymphocytic inflammation of the bridge and cerebellum. A clinical case
Agnieszka Meller |
13:10 – 13:20 |
Multiparameter differential diagnosis of multiple sclerosis and systemic inflammatory diseases involving the central nervous system
Mariusz Stasiołek |
13:20 – 13:30 |
Relationship between the permeability of the blood-brain barrier and antibodies to aquaporins in patients with neuromyelitis optica diseases and with multiple sclerosis
Michalina Jasiak-Zatońska |
09:00 – 10:30 |
CLINICAL CASE FORUM - YOUNG NEUROLOGISTS
Aleksandra Pietruczuk Karolina Piasecka-Stryczyńska |
09:00 – 09:15 |
Hemiplegic migraine in the puerperium - a case report
Anna K. Szewczyk |
09:15 – 09:30 |
Male patient with Kennedy syndrome - case report
Julia Kwaśniak |
09:30 – 09:45 |
Hyperammonemia in the course of ornithine transcarbamylase gene mutation as a cause of cognitive impairment - case presentation
Aleksandra Przybycień |
09:45 – 10:00 |
Eagle syndrome as a rare cause of ischaemic stroke
Paweł Wrona |
10:00 – 10:15 |
Cep leg syndrome in a familial form of amyotrophic lateral sclerosis - a case report
Ewa Zapalska |
10:15 – 10:30 |
Discussion
|
10:30 – 12:30 |
Break
|
12:30 – 13:30 |
OWN WORKS:
NEURODEGENERATIVE DISEASES Sławomir Budrewicz |
12:30 – 12:40 |
Prognostic factors of early neurological deterioration in Wilson's disease during the 6-month follow-up
Agnieszka Antos |
12:40 – 12:50 |
The importance of planning assessment and cognitive control in neuropsychological diagnosis of patients with Richardson's variant of progressive supranuclear palsy
Paulina Skrzypkowska |
12:50 – 13:00 |
Estrogen derivatives and hydrogen peroxide as promising biomarkers in Parkinson's disease
Anna Roszman |
13:00 – 13:10 |
Eye saccade dysfunction as a biomarker of brain atrophy in Huntington's disease
Natalia Grabska |
13:10 – 13:20 |
CIDP-like polyneuropathy in the course of treatment with the Duodop system
Radosław Piekarski |
13:20 – 13:30 |
First human preliminary safety evaluation of DYSTROPHIN EXPRESSING CHIMERIC (DEC) CELLS therapy in patients with Duchenne muscular dystrophy
Adam Niezgoda |
09:00 – 10:30 |
SPECIAL SESSION - THE HEART AND THE BRAIN
Piotr Pruszczyk prof. dr hab. n. med. Konrad Rejdak |
09:00 – 09:20 |
The many faces of embolism - from diagnosis to comprehensive treatment
Piotr Pruszczyk |
09:20 – 09:40 |
Cardiovascular risk factors in the etiopathogenesis of ESUS
Rafał Dąbrowski |
09:40 – 10:00 |
Endovascular treatment in Poland
Agnieszka Słowik |
10:00 – 10:20 |
Mechanical thrombectomy treatment protocol in the Lublin voivodeship
dr n. med.
Piotr Luchowski
Moderator
dr hab. n. med.
Anna Szczepańska-Szerej
Anna Szczepańska-Szerej |
10:20 – 10:30 |
Discussion
|
10:30 – 12:30 |
Break
|
12:30 – 13:30 |
OWN WORKS: SEIZURES EPILEPSY
|
12:30 – 12:42 |
Depressive and cognitive disorders and life quality of patients with epilepsy
dr Klaudia Jeżowska-Jurczyk |
12:42 – 12:54 |
Genetic ontology as one of epilepsy diagnosis descriptors. Neuroterminal-HPO system
Piotr Zwoliński |
12:54 – 13:06 |
Efficacy and safety of the stimulation of the anterior thalamic nuclei in the treatment of drug-resistant epilepsy - presentation of cases
Magdalena Konopko |
13:06 – 13:18 |
Comparative analysis of the network of functional connections of the brain in epilepsy patients based on simultaneous EEG-FMRI registrations
mgr inż. Nikodem Hryniewic |
13:18 – 13:30 |
Discussion
|
09:00 – 10:30 |
REVIEW SESSION: NEUROREHABILITATION
Iwona Sarzyńska-Długosz dr n. med. Jarosław Szczygieł |
09:00 – 09:20 |
Sarcopenia and the effects of rehabilitation after stroke
Iwona Rotter |
09:20 – 09:40 |
Pharmacologically-supported rehabilitation after stroke - what do the recommendations suggest?
Iwona Sarzyńska-Długosz |
09:40 – 10:00 |
Post-stroke quality of life - a measure of rehabilitation success
Józef Opara |
10:00 – 10:20 |
Orthopedic supplies after stroke - what a neurologist should know?
Bożena Kłysz |
10:20 – 10:30 |
Discussion
|
10:30 – 10:45 |
Break
|
10:45 – 11:45 |
SPONSORED SESSION
|
10:45 – 11:15 |
Lecture sponsored by
Neurological disorders associated with vitamin B12 deficiency prof. dr hab. n. med. Jarosław Sławek |
11:15 – 11:45 |
Lecture sponsored by
Dyskinesia or is it already a verdict in Parkinson's disease? prof. dr hab. n. med. Jarosław Sławek Andrzej Bogucki |
11:45 – 12:30 |
Break
|
12:30 – 13:30 |
OWN WORKS: VASCULAR DISEASES
Adam Kobayashi |
12:30 – 12:40 |
Validation of the Polish version of the stroke scale of the National Health Institute (PL-NIHSS)
Adam Wiśniewski |
12:40 – 12:50 |
Periprocedural blood pressure fluctuations and complications of treatment of ischemic stroke by mechanical thrombectomy: symptomatic intracerebral hemorrhage and malignant cerebral edema
Marcin Wiącek |
12:50 – 13:00 |
Cyclical monitoring of the quality of hospital processes as a tool supporting the improvement of the efficiency of Polish stroke units: RES-Q 2017-2020
Michał Karliński |
13:00 – 13:10 |
The role of NLR (neutrophils / lymphocytes) in predicting delirium in people with acute stroke
Marta Bott-Olejnik |
13:10 – 13:20 |
Diagnostics of atrial fibrillation using a mobile electrocardiograph recorder in a group of patients in the acute phase of ischemic stroke
Marta Leńska-Mieciek |
13:20 – 13:00 |
Discussion
|
Saturday, 17 September |
10:00 – 13:00 |
WORKSHOP: Neuroimaging interpretation in making important clinical decisions: a patient qualified for reperfusion therapy and a patient with secondary hemorrhage
Medical Simulation Center, Medical University |
Saturday, 17 September |
14:15 – 17:25 |
Family Neurology Symposium - the most common neurological symptoms in the clinical practice of a primary care physician (for details, see "Primary Care Physician's Symposium")
|
14:15 – 15:45 |
Part I The most common neurological symptoms in the GP practice - session sponsored by
|
14:15 – 14:35 |
Diagnosis and treatment of tremors in Parkinson's disease in GP practice
Magdalena Boczarska-Jedynak |
14:35 – 14:55 |
No neurologist or ENT specialist - dizziness in the GP's office
Beata Błażejewska-Hyżorek |
14:55 – 15:15 |
Dementia syndromes
Piotr Wierzbiński |
15:15 – 15:35 |
Neuropathic pain practical tips
Małgorzata Malec-Milewska |
15:35 – 15:45 |
Discussion
|
15:45 – 16:15 |
Break
|
16:15 – 17:25 |
Part II Diagnostic pathways for a patient with neurological diseases - from primary care physician to neurological specialist
|
16:15 – 16:35 |
Diagnostic pathway for a patient with myasthenia gravis
Lecture under the auspices of
Elżbieta Klimiec-Moskal |
16:35 – 16:55 |
Diagnostic pathway for a patient with epilepsy
prof. dr hab. n. med. Konrad Rejdak |
16:55 – 17:15 |
Diagnostic pathway for a patient with MS
Lecture sponsored by
prof. dr hab. n. med. Konrad Rejdak |
17:15 – 17:25 |
Discussion
|
Saturday, 17 September |
14:15 – 17:15 |
TRAINING WORKSHOP: EDSS
Monika Adamczyk-Sowa Monika Nojszewska Anna Jamroz-Wiśniewska Mariusz Stasiołek Aleksandra Podlecka-Piętowska Agata Walczak Sławomir Wawrzyniak |
14:15 – 17:15 |
WORKSHOP: BOTULINUM TOXIN
|
14:15 – 15:15 |
How to treat dystonia
Michał Schinwelski |
15:15 – 16:15 |
How to treat spasticity
Michał Schinwelski |
16:15 – 17:15 |
How to treat chronic migraine
Magdalena Boczarska-Jedynak |
14:15 – 15:55 |
WORKSHOP: SECTION OF NEUROSONOLOGY PTN
Joanna Wojczal Marta Skowrońska |
14:15 – 14:35 |
Patient with arterial blood inflammation
Joanna Wojczal |
14:35 – 14:40 |
Discussion
|
14:40 – 15:00 |
Patient with carotid dissection
Marta Skowrońska |
15:00 – 15:05 |
Discussion
|
15:05 – 15:25 |
Patient with muscle tremors
Radosław Kaźmierski |
15:25 – 15:30 |
Discussion
|
15:30 – 15:50 |
Patient with upper thoracic outlet syndrome
Grzegorz Kozera |
15:50 – 15:55 |
Discussion
|